Thursday, May 23, 2013 | 7:00 PM - 8:30 PM
Speakers: Steve Ettlinger (Author), Dwight Eschliman (Photographer), J. Kenji Lopez-Alt (Serious Eats)
Moderator: Dan Pashman (Journalist)
Whether it's mined from deep in the earth or grown on a farm, the ingredients in modern food have to come from somewhere. Join us as we learn just where some of the ingredients in your favorite snacks come from and just how combining certain elements can lead to either a food fantasy or fatal fare! Part of the Science and the Seven Deadly Sins Series.
Friday, May 24, 2013 | 8:30 AM - 4:30 PM
Speakers: Scott A. Armstrong (Memorial Sloan-Kettering Leukemia Center), Stephen Baylin (The Johns Hopkins University School of Medicine), Robert Copeland (Epizyme), Vicki L. Goodman (GlaxoSmithKline), Haitao Li (Tsinghua University, China), Shirley Liu (Dana Farber Cancer Institute), Robert Sims (Constellation), Alexander Tarakhovsky (The Rockefeller University)
Epigenetic research has shown that heritable changes in cancer cell transformation occur beyond the primary DNA sequence. This symposium reviews epigenetic regulators in cancer development and progress in designing therapies targeting the epigenome.
May 28 - 29, 2013 | Spain
Explore Plasmodium vivax biology and genomics; drug resistance and discovery; and recent clinical trial and in-field efforts in P. vivax malaria prevention, treatment, control, and elimination.
Thursday, May 30, 2013 | 9:00 AM - 5:00 PM
Review progress on key aspects of the Plasmodium vivax research agenda as they pertain to malaria treatment, control, and elimination through a series of free, interdisciplinary workshops.
Monday, June 3, 2013 | 1:00 PM - 4:00 PM
Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Rodney Rothstein (Columbia University Medical Center), Lorraine Symington (Columbia University Medical Center)
Keynote Speaker: Stephen West (London Research Institute, Cancer Research UK)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Wednesday, June 5, 2013 | 12:00 PM - 4:00 PM
Keynote Speaker: Alanna Schepartz (Yale University)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Alana Schepartz of Yale University and a poster session.
Thursday, June 6, 2013 | 8:30 AM - 6:30 PM
Organizers: Sharon Akabas (Columbia University), Gerald Friedman (The Mount Sinai Hospital), Martin Kohlmeier (University of North Carolina), Charlotte Pratt (National Institute of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)
This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.
June 11 - 13, 2013
Organizers: Mark E. Davis (California Institute of Technology, Pasadena), Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School), Brooke Grindlinger (The New York Academy of Sciences), Melanie Brickman Stynes (The New York Academy of Sciences), Roger Kornberg (Stanford University School of Medicine), Robert S. Langer (Massachusetts Institute of Technology), Konstantin Severinov (Rutgers the State University of New Jersey)
Throughout the past decade, nanoparticles and specifically nanoparticle drug delivery systems, have emerged at the forefront of cancer therapies. This conference will discuss: nanodiagnostics for cancer biomarkers and imaging, toxicity and safety; nanovaccines and nanoimmunotherapeutics; targeted delivery in tumors; and nanoparticle-based gene therapy.
Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM
In-house event is SOLD OUT! Register for the live webinar.
Speakers: Martin J. Blaser (New York University School of Medicine), Sir Harry Burns (Scottish Government, Scotland), Patrice D. Cani (Université Catholique de Louvain, Belgium), Fred H. Degnan (King & Spalding LLP), Joël Doré (Institut National de la Recherche Agronomique, France), Jane A. Foster (McMaster University, Canada), Gary Frost (Imperial College London, United Kingdom), Patricia L. Hibberd (Harvard Medical School / Massachusetts General Hospital for Children), John Hutton (University of York, United Kingdom), Todd Klaenhammer (North Carolina State University), David A. Mills (University of California, Davis), Max Nieuwdorp (University of Amsterdam, The Netherlands), Bruno Pot (Institut Pasteur de Lille, France), Rowena Pullan (Pfizer Consumer Healthcare), Helen E. Raybould (University of California, Davis), Gregor Reid (Western University / Lawson Health Research Institute, Canada), David A. Relman (Stanford University School of Medicine), Andrew Serazin (Matatu LLC)
Explore research and policy strategies to translate scientific knowledge on the convergence of the microbiome, prebiotics, probiotics, and host physiology into nutritional and therapeutic applications for inflammation, obesity, diabetes, gastrointestinal disease, and malnutrition.
June 19 - 20, 2013
Conference Planning Committee: Claudio Carini (Pfizer Inc.), Teresa Compton (Biogen Idec (Conference Chair)), Marion Kasaian (Pfizer Inc.), Theodora Salcedo (Bristol-Myers Squibb Company), Anne Vogt (F. Hoffmann-La Roche Ltd)
Scientific Advisory Board: Leonard Calabrese (Cleveland Clinic), Paola Cinque (Hospital San Raffaele), David Clifford (Washington University School of Medicine), Robert Garcea (University of Colorado at Boulder), Eugene Major (National Institute of Neurological Disorders and Stroke), Kenneth Tyler (University of Colorado Anschutz Medical Campus), Thomas Weber (University of Hamburg)
New basic science and clinical findings relevant to the pathogenesis, mitigation, cure, and risk stratification of Progressive Multifocal Leukoencephalopathy will support a discussion of current challenges and future directions for PML treatment.
Friday, May 17, 2013 | 8:00 AM - 4:30 PM
Speakers: Myron S. Cohen (UNC School of Medicine), Chris Collins (amfAR, The Foundation for AIDS Research), Michele R. Decker (Johns Hopkins Bloomberg School of Public Health), Tim Horn (Treatment Action Group), Rick King (IAVI), Luiz Loures (UNAIDS), Mary A. Marovich (NIAID), Nelson L. Michael (Walter Reed Army Institute of Research), Julio Montaner (BC Centre for Excellence in HIV / AIDS), John P. Moore (Weill Cornell Medical College), Robert R. Redfield (University of Maryland School of Medicine), Bill Snow (Global HIV Vaccine Enterprise), Magdalena Sobieszczyk (Columbia University Medical Center), Annie Sparrow (Mount Sinai Global Health), Daniel Tietz (ACRIA), Mitchell Warren (AVAC), Jane Waterman (IAVI)
The UNAIDS "three zeros" strategy provides a clear vision for future HIV / AIDS research and policy. This symposium tackles communication and collaboration, capacity-building for HIV prevention, care, and treatment, vaccine trials and a case study.
Thursday, May 16, 2013 | 11:30 AM - 3:00 PM
Speakers: Uldis Blukis, Charles Byrne, Herb Klitzner, Hillel Schiller
The Lyceum Society comprises the Academy's retired and semi-retired members. Talks cover various scientific fields. All Academy members are welcome.
Tuesday, May 14, 2013 | 6:00 PM - 7:30 PM
Speaker: Erika Lorraine Milam (Princeton University)
The History and Philosophy of Science Section of the New York Academy of Sciences holds multiple meetings covering a wide range of topics within the field.
Monday, May 13, 2013 | 7:00 PM - 8:30 PM
Moderator: Ingrid Wickelgren (Scientific American Mind)
Speakers: Clancy Blair (New York University), Amishi P. Jha (University of Miami)
Join us to learn about the recent trends in education to foster social and emotional learning in classrooms is aimed at nurturing such fundamental traits as self-control, focus and perseverance in children.
Monday, May 6, 2013 | 8:15 AM - 4:00 PM
Speakers: Kurt R. Brunden (University of Pennsylvania), Grant J. Carr (AMRI), Gabriela Chiosis (Memorial Sloan-Kettering Cancer Center), Jerold Chun (The Scripps Research Institute), Bonnie M. Davis (Synaptec), Chad Dickey (University of South Florida), Frank E. Koehn (Pfizer Global R&D), David J. Newman (National Cancer Institute, NIH), Salvatore Oddo (University of Texas Health Science Center, San Antonio), Giulio Maria Pasinetti (Mount Sinai School of Medicine)
Alzheimer's disease may benefit from the novel chemistries found in natural products. This conference explores drug discovery from natural products, including novel approaches and technologies, and promising Alzheimer's drug discovery programs.
Are you interested in informal science programs? Do you want to help create a larger science community? Dr. Jeanne Garbarino, Director of Science Outreach at The Rockefeller University, explains how her interest in science communication—via blogging, social media and research programs—has helped her reach new audiences.
Dream of independence and your own company? Human Workflows and SciPhD co-founder Randy Ribaudo discusses the rewards and challenges of entrepreneurship, and how scientists can apply their problem-solving skills—and improve their communication skills—to successfully start and run a business.
Interested in the business of science or how research programs get designed, funded, and managed? Hear Mike Holland discuss how he went from imaging aluminum uptake in soybean roots to overseeing multi-billion dollar federal research programs.
Interested in translating your science critical thinking skills to the market? Listen to Caroline Corner describe how she left the lab bench to break into the finance industry as an equity research analyst and consultant.
Want to learn more about consulting? Hear Jeremy Buzzard, a PhD in molecular and cellular biology, talk about his career in management consulting as a partner at McKinsey & Co.
Not ready to leave the bench after grad school? Find out how training in an industry lab versus an academic lab compares from Justin Hall, currently a postdoctoral fellow at Pfizer.
Intrigued by the forensic scientists on shows like CSI? Find out what the job's really like from criminalist Craig O'Connor, who joined the Office of Chief Medical Examiner in NYC after earning a PhD in genetics.
If you're thinking about a career in academia, find out how Rachel O'Neill transitioned from her postdoc to a faculty position, as well as the benefits and challenges of this path.
Hear Laura Malisheski discuss how she transitioned from her postdoc in neuroscience to advising others on their career paths.
If working with scientists to patent their inventions sounds appealing, hear Ryan Murphey talk about how you can get into intellectual property law with a PhD.
For those with a passion for communicating science: Beth Schachter details her journey as an assistant professor who left the bench to pursue a career in science communications.
If teaching is your calling, tune in to Ellen Cohn, an immunologist, talk about her transition into teaching middle school science.
Want to be a journal editor? Listen to Brooke Grindlinger discuss her path from being a PhD in microbiology to an editor at the Journal of Clinical Investigation.
Interested in publishing? Hear Jennifer Henry discuss how she went from studying plant molecular biology to being a publishing manager at Nature.
Organizers: Johanne Morne (New York State Department of Health AIDS Institute), Sonja Noring (New York State Department of Health AIDS Institute), Cheryl Smith (New York State Department of Health AIDS Institute), AIDS Institute Social Media Workgroup (New York State Department of Health AIDS Institute), Brooke Grindlinger (The New York Academy of Sciences), and Kerstin Hofmeyer (The New York Academy of Sciences)
This eBriefing looks at the impact of digital technologies on clinical care, especially for HIV and other sexually transmitted infections, exploring eHealth strategies for patient-centered care and clinical decision support.
Edited by Olivera J. Finn
(University of Pittsburgh, Pittsburgh, Pennsylvania) and Gerold Schuler
(University Hospital of Erlangen, Erlangen, Germany)
This Annals volume presents papers that discuss progress of immunology research toward the development of cancer vaccines.
Moderator: Tom Vanderbilt (Author)
Panelists: Mariela Alfonzo (Polytechnic Institute at New York University), Kaid Benfield (Natural Resources Defense Council), and Hunter Reed (FAST NYC)
As part of the Academy's Science and the Seven Deadly Sins series, a panel discussed urban design in NYC and explored how the built environment affects public health.
Edited by Narinder K. Mehra
(All India Institute of Medical Sciences, New Delhi, India)
This Annals volume presents papers from the fifth congress of the Federation of Immunological Societies of Asia-Oceania.
Organizers: Robert Martone (Covance Biomarker Center of Excellence), Harald Murck (Covance Neuroscience Medical and Scientific Services), and Jennifer Henry (The New York Academy of Sciences)
Speakers: Ronald S. Duman (Yale University School of Medicine), Guosong Liu (Tsinghua University, China), Jorge Quiroz (Roche), Simone B. Sartori (University of Innsbruck, Austria), and Carlos A. Zarate (National Institute of Mental Health, NIH)
Major depression is a devastating illness; current therapies based on monoamine neurotransmitters are beneficial for only one in ten patients. This eBriefing reviews a paradigm shift in treatment that targets the glutamatergic neurotransmitter system.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
February 23, 2010
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
January 5, 2010
New York Governor David Paterson has set a target of reducing greenhouse gas emissions in the state by 80% by the year 2050. Stakeholders met at the Academy to discuss strategies for reaching this goal.